Home >> Professional Blog

MiMedx Announces Record Results for First Quarter of 2015 and Raises full-year Guidance

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced its record results for the first quarter of 2015.

The Company also announced the decision of its Board of Directors to authorize an increase of $10 million to the Company's Share Repurchase Program. This action increases the total authorized to $30 million since the program commenced on May 12, 2014.

Read the entire news release